BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38506430)

  • 1. Sex differences in mortality and liver-related events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Zhou H; Chen H; Lu H; Wu B; Zhang S; Gu Y; Zhou G; Xiang J; Yang J
    Liver Int; 2024 Jul; 44(7):1600-1609. PubMed ID: 38506430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants.
    Wang Y; O'Neil A; Jiao Y; Wang L; Huang J; Lan Y; Zhu Y; Yu C
    BMC Med; 2019 Jul; 17(1):136. PubMed ID: 31296205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Souza M; Diaz I; Barchetta I; Mantovani A
    Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
    Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
    Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
    Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
    Hwang YC; Ahn HY; Park SW; Park CY
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis.
    Zhang X; Mou Y; Aribas E; Amiri M; Nano J; Bramer WM; Kavousi M; de Knegt RJ; Asllanaj E; Ghanbari M
    Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
    Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis.
    Saokaew S; Kanchanasurakit S; Thawichai K; Duangprom P; Wannasri M; Khankham S; Kositamongkol C; Chaiyakunapruk N; Phisalprapa P
    Medicine (Baltimore); 2021 Feb; 100(5):e24557. PubMed ID: 33592910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Ha J; Yim SY; Karagozian R
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2496-2507.e5. PubMed ID: 36442727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Chen W; Wang M; Jing X; Wu C; Zeng Y; Peng J; Cai X
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2051-2065. PubMed ID: 32579269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Gong S; Song J; Wang L; Zhang S; Wang Y
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):132-8. PubMed ID: 26545082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
    Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Thomas JA; Kendall BJ; Dalais C; Macdonald GA; Thrift AP
    Eur J Cancer; 2022 Sep; 173():250-262. PubMed ID: 35944373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
    Li J; Zou B; Yeo YH; Feng Y; Xie X; Lee DH; Fujii H; Wu Y; Kam LY; Ji F; Li X; Chien N; Wei M; Ogawa E; Zhao C; Wu X; Stave CD; Henry L; Barnett S; Takahashi H; Furusyo N; Eguchi Y; Hsu YC; Lee TY; Ren W; Qin C; Jun DW; Toyoda H; Wong VW; Cheung R; Zhu Q; Nguyen MH
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):389-398. PubMed ID: 30902670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis.
    Morrison AE; Zaccardi F; Khunti K; Davies MJ
    Liver Int; 2019 Mar; 39(3):557-567. PubMed ID: 30358050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.